We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » FDA Seeks Participants for Pilot Home Use Device Labeling Database

FDA Seeks Participants for Pilot Home Use Device Labeling Database

April 17, 2015

The U.S. FDA’s Center for Devices and Radiological Health is launching a public database of labeling for home use devices and is looking for devicemakers to help test it later this year.

The goal of the CDRH Home Use Labeling Pilot program is to improve the safety of medical devices that are used in the home, the FDA says, noting that people may lack specific training in use of a device and are more dependent on the labeling and package inserts than medical professionals. Moreover, if the device is used over a period of years, the original labeling may be lost or not reflect updates to safety information and instructions for use.

Some manufacturers address this concern by putting safety information on their websites, the FDA acknowledges. Those sites often focus on newer products and don’t include information on older models or products no longer being sold. Further, most manufacturers don’t post all labeling and package inserts for every device they have listed, the agency says.

The CDRH database will include information on labels and package inserts for all home-use devices. Consumers will be able to access the database through the FDA website and search for information on specific devices.

During the pilot, participants will be asked to test the electronic submissions process and practice submitting labels and package inserts in PDF format. Company feedback will be used to evaluate the database. Submitted packaging and labeling will not be evaluated for potential regulatory concerns and the database will be private during the trial, the FDA says.

Companies interested in participating in the project may apply throughout the month of May. The program will run from July 1 through Dec. 31.

For information, contact Mary.Brady@fda.hhs.gov. No more than nine manufacturers will be asked to participate.

View the announcement at www.fdanews.com/04-20-15-homeuse.pdf. — Elizabeth Orr

Regulatory Affairs

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • UKflag.jpg

    UK Study Says Single Shot of Pfizer/BioNTech Vaccine Significantly Lessened Asymptomatic Infections

  • emergency use authorization approved

    Eurofins Receives FDA Emergency Authorization for Over-the-Counter COVID-19 Test

  • FDA clears text

    Vetex Medical’s Thrombectomy Catheter Cleared by FDA

  • 100Bills_flatmoney.gif

    Merck Purchases Rights to Debiopharm’s Xevinapant for More Than $1 Billion

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing